Home > Insider Trading > Filing (0001209191-22-011731)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1828522	Effector Therapeutics Inc.	EFTR	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1293973	B Christopher Ehrlich	C/O Effector Therapeutics, Inc. 142 North Cedros Avenue, Suite B Solana Beach CA 92075		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2022-02-14	2,000	$4.45	15,000	No	4	P	Direct
Common Stock	Acquisiton	2022-02-18	1,000	$4.30	16,000	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	142,168	Indirect	By Locust Walk Partners LLC
Common Stock	1,034	Indirect	By Locust Walk Partners LLC

Footnotes

The price reported in Column 4 is a weighted average price. These shares were purchased in two transactions at prices ranging from $4.40 to $4.50. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Represents shares held directly by the Sponsor, of which Locust Walk Partners LLC ("LWP") is a member. LWP has allocated these shares to the reporting person.
Represents shares held directly by the Sponsor, of which LWP is a member. LWP has allocated these shares to the reporting person's spouse.